Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Life Sciences Solutions
  • Healthcare Solutions
  • Medical Device and Diagnostic
  • U.S. Government
Life Sciences Solutions

Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.

Learn More
Life Sciences Solutions
Healthcare Solutions

Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.

Learn More
Healthcare Solutions
Medical Device and Diagnostic Solutions

Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.

Learn More
Medical Device and Diagnostic Solutions
U.S. Government Solutions

For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.

Learn More
U.S. Government Solutions
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
U.S. BLOGS

Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!

LEARN MORE

U.S. INSIGHTS LIBRARY

"Browse our library of insights and thought leadership.

LEARN MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

LEARN MORE
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

LEARN MORE

FEATURED WEBINAR

"Top Issues for Pharma to Watch in 2022 and 2023

WATCH NOW
MAIN/Contact Us
Contact Us/
Market Insights

Market Insights

From U.S. Progress Point: Market trends and dynamics impacting your U.S. business today and strategic plans for tomorrow
Subscribers' Circle
Locations United States U.S. Progress Point Market Insights

Latest On Launch

Launch Excellence, U.S. Edition: The Rewrite of the Business Launch

Today, a successful launch is no longer defined by just dollars — it’s defined by the number of patients reached, acquired, and retained. To reflect this new reality, we’ve refined our take on the modern launch, and carefully considered what needs to change to achieve commercial success in a pressurized environment.

In this paper, IQVIA experts discuss the clear need for a rewrite of the modern launch playbook.

LAUNCH INTO THE FUTURE
WEBINAR
Launch Excellence, U.S. Edition
The launch environment is more pressurized than ever before. The convergence of legislative requirements, payer expectations of price and evidence, and meeting patients’ needs means an aligned launch strategy is mission critical. This is the first of a three-part series and will focus on the first phase of launch – acquiring patients.
WATCH ON-DEMAND
ON THE HORIZON
Top Trends to Watch in 2024
As always, the turn of the year brings a sense of possibility – and it feels especially heightened for 2024. Looking ahead, we’ve curated a thought-provoking collection of ideas, predictions, and trends that we anticipate will have an outsized impact over the coming year.

Read the full piece to explore our complete list of top trends for 2024 – areas of growth and evolution – that will impact the pharma industry and healthcare.
What's ahead in 2024

An Alzheimer’s perspective

How Will We Remember This Moment?

For the first time, patients living with Alzheimer’s disease and their families have options. Yet, the recent approvals and market performance of disease-modifying treatments demonstrate a glaring truth: the healthcare system is unprepared to deliver the hope that these new treatments promise. What can the healthcare ecosystem do to be ready for their impact?

In this paper, we tackle what is needed to reach as many patients as possible, diving deep into the alignment that must exist in and between five key areas: advocacy, approval, adoption, access, and adherence.

BRACE FOR IMPACT
Mounjaro: A New Era of Preventive Care and Consumer Health

With less than a year on the market, Mounjaro is already performing like few other medications we have seen in the past decade. Unpacking this remarkable launch makes it clear that Mounjaro isn’t just an outlier; it is a torchbearer for an entirely new category of medicine and demonstrates the shifting (or blurring) line between consumer and medical avenues of care.

A REMARKABLE LAUNCH
Transitional Assistance Programs in the GLP-1 Market

Transitional assistance is now part of the standard launch brand toolkit, but little research has been conducted on the impact that these programs have on long-term brand success. Using a selection of GLP-1s as an entry point, this blog measures the role and impact of manufacturer-sponsored patient support at launch and beyond.

THREE LAUNCH STORIES

INSIGHT BRIEF

Ten MedTech Trends to Watch in 2024

2024 will be a year of diverse challenges for MedTech companies, some of which presage potentially significant changes before the decade is over. This insight brief covers ten of the top trends IQVIA MedTech experts see on the horizon and the implications for the MedTech industry.

EXPLORE 2024 TRENDS

Market Access Insights

Navigating the market access and financial landscape

The path to the market access summit can be steep, winding, and, at times, unclear. From navigating the complexities of payer requirements to disruption from the Inflation Reduction Act of 2022, you require the best equipment, knowledge, and insights to climb with confidence and reach the apex of your products’ potential.

From the IQVIA Institute for Human Data Science

INSTITUTE REPORT
U.S.-India Medicine Partnership: India's Contribution to the U.S. Healthcare System

Institute Report
Trends in Adult Vaccination in the U.S.

WEBINAR
The Global Use of Medicines 2024

Institute Report
Trends in Global Adult Vaccination: A View from Five Global Cities

Institute Report
The Use of Medicines in the U.S. 2023

Prev
Next
FROM THE U.S. PROGRESS POINT EDITORIAL BOARD
Their Finest Hour: Medical Affairs in a Disrupted World
Our perspective on the new Medical Affairs collaboration model, the importance of redefining value and the demand for alignment between pharma, HCPs, and healthcare systems to improve performance and achieve optimal health outcomes.
MISSION-CRITICAL MEDICAL AFFAIRS

See the whole board

The Inflation Reduction Act of 2022 is poised to be a watershed event for the U.S. healthcare system, setting up a complex chess game for pharmaceutical manufacturers.

In this brief, a team of IQVIA industry experts – from policy and market access to brand strategy and financial planning – establish the contours of the conversation and elucidate both short-term impact and long-term implication.

CONSIDER YOUR OPENING GAMBIT
IQVIA MONTHLY LAUNCH TRACKER
A real-time conversation on launch
What products are leading the launch pack? Is the therapy area mix changing? What key markets are bucking trends and creating a new normal? Tap into the IQVIA Monthly Launch Tracker for this and more. Data updated through March 2024.
Leaders of launch

U.S. Launch Landscape

In this and future issues, we will rigorously investigate the past and present in an effort to understand the future.

  • What is the definition of launch success?
  • Is there an optimal way to engage and educate providers on new products?
  • What is the impact of patient behavior, access, and affordability?
  • How much can a launch-naïve company rely on historical norms versus brave new pathways?
Get Answers
U.S. Progress Point Subscribers' Circle: First-looks, exclusive content, and more.
Subscribe
Contact Us